Fig. 1From: The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumorsThe 3-year progression free survival rates of the PM group and SBRT groups. The 3-year progression-free survival rate of the PM group were better than that of SBRT groups (42% vs 11%, p = 0.01)Back to article page